ENTRY       D11925                      Drug
NAME        Lumasiran (USAN/INN)
FORMULA     C530H712F10N173O320P43S6
EXACT_MASS  16332.1641
MOL_WEIGHT  16340.5372
REMARK      ATC code: A16AX18
            Chemical structure group: DG03131
            Product (DG03131): D11926<US>
EFFICACY    Oxalate production reduction
  TYPE      RNA interference (RNAi) drug
COMMENT     Treatment of primary hyperoxaluria type 1
TARGET      HAO1 [HSA:54363] [KO:K11517] (mRNA)
  PATHWAY   hsa00630(54363)  Glyoxylate and dicarboxylate metabolism
            hsa04146(54363)  Peroxisome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX18 Lumasiran
                  D11925  Lumasiran (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Oxidases
                HAO1
                 D11925  Lumasiran (USAN/INN)
DBLINKS     CAS: 1834610-13-7
///
